Approaches to implementing automation in cell therapy manufacturing
The need for standardization and automation are critical drivers of innovation in cell therapy manufacturing. Implementation of an automated, closed workflow minimizes open processes and manual touchpoints, increases reproducibility, and improves traceability. This has the potential to reduce manufacturing failures and lower the cost of goods sold (COGS), thereby facilitating increased patient access. In this webinar, industry experts will discuss various approaches to current Good Manufacturing Practice (cGMP) manufacturing of gene-modified cell therapies at industrial scale.
Key learning objectives
- Discover innovations in fit-for-purpose, closed manufacturing
- Explore considerations for designing or selecting instruments that are closed to achieve automation
- Learn about the time and cost-saving advantages of implementing a fully automated manufacturing workflow that is regulatory compliant
- Discover the importance of technology as it relates to automation and standardization within cell therapy manufacturing
Who should attend?
- Process development managers
- Process engineer managers
- Head of manufacturing / manufacturing science and technology
- R&D scientist
- Project manager (Operations)
- Professor/ principle investigator
Certificate of attendance
All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.
Speakers
